1 SCIENTIFIC ARTICLE Current Status of Vaccines & Treatments related to SARS COV-2 4 POEM Not On The Same Boat 5 IPA-MSB-SF During COVID 10 INTERVIEW Dr. Krishna Iyer 12 POEM The Crisis 13 INDIA IN TIMES OF COVID 17 VACCINES AROUND THE WORLD 18 INTERVIEW Dr. Maushmi Kumar 21 TEAM OF IPA-MSB-SF 2020-21 Committee Photos 41 SCIENTIFIC ARTICLE 44 Impact of Covid-19 on the Environment POEM Raising the Best in Ourself 45 ART GALLERY 46 INTERVIEW Ms. Bhagayashree Parab 49 POEM अनदेखा अनजाना एक अजूबा ।। 50 ART GALLERY 51 OUR SPONSORS
1 CURRENT STATUS OF VACCINES AND TREATMENTS RELATED TO SARS COV-2 RUCHIRA JOSHI NMIMS SPPSPTM In late December of 2019, people of hence proving that the novel Wuhan city, Hubei province in China coronavirus has a greater pandemic started showing up at hospitals potential (T. Liu et al., 2020). reporting respiratory failures and pneumonia like symptoms. The As on 26th May 2020, there are causative organism was later more than 5.5 Million cases identified as novel coronavirus and worldwide and more than 346,000 named SARS-CoV-2 by ICTV deaths reported highlighting the (International Committee on urgent need of vaccine/treatment Taxonomy of Viruses) and 2019-nCoV options for the disease. by WHO (Zhang et al., 2020). Although with a fatality rate of 2.3 Available treatment options focus on (.http://weekly.chinacdc.cn/en/article repurposing of available medicines /id/e53946e2-c6c4-41e9-9a9b- for SARS or MERS for immediate fea8db1a8f51) which is smaller than treatment of patients using that of SARS (9.5%) and much smaller antiviral drugs like Lopinavir, than MERS (34.4%) (Chen, 2020; Ritonavir, Avipiravir, Darunavir Munster et al., 2020), and Remdesivir. Interestingly, Hydroxychloroquine, The novel coronavirus has got a developed as an antimalarial drug is reproductive rate of 3.28 (Y. Liu et al., showing promise in COVID-19 2020) which is greater than SARS treatment by interrupting the (1.7-1.9) and much greater than MERS glycosylation process. (<1),
2 CURRENT STATUS OF VACCINES AND TREATMENTS RELATED TO SARS COV-2 RUCHIRA JOSHI NMIMS SPPSPTM Lopinavir, Darunavir and Ritonavir Research Center at NIH, is till now (Hull & Montaner, 2011) are bonafide the most successful by entering Phase protease inhibitors, while Favipiravir 1 clinical trials. Even BNT162 mRNA inhibits viral RNA dependent RNA vaccine developed by BioNTech and polymerase. Remdesivir was initially Pfizer has started Phase 1/2 clinical developed for the Ebola virus trial in Germany. (Mulangu et al., 2019) and likely terminated RNA synthesis (Agostini Similar vaccine developed by CureVac et al., 2018). is still in the preclinical stage. Some recombinant protein based vaccine Other options include recombinant candidates are-ExpresS2ion, viral- ACE-2 receptors (Kadam & Wilson vector based vaccine candidates are- 2017; Teissier et al., 2011) to bind and Vaxart, Geovax, DNA vaccines are- neutralize the virus and prevent lung Inovio and live attenuated vaccines damage, thus inhibiting it’s are being developed by Codagenix pathophysiology. along with the Serum Institute of India, and work is also going on Clinical trials have also started about other inactivated virus regarding the use of convalescent vaccines in the pipeline. J&J and serum/plasma therapy in infected Sanofi have also joined forces for patients. Polyclonal IgG antibody developing a vaccine. (Luke et al., 2016) could also be used and has been proved to be successful in MERS-CoV treatment in animal models mRNA based vaccine developed by Moderna and Vaccine
3 CURRENT STATUS OF VACCINES AND TREATMENTS RELATED TO SARS COV-2 RUCHIRA JOSHI NMIMS SPPSPTM The Indian system of medicine or Ayurveda has also come up with various approaches to tackle COVID- 19. Most of them include immunity- boosting therapies like Chyawanprakash, Kadha and Rasayana. Use of homeopathic medicines like People shouldn’t be led by false Arsenicum Album 30 have been rumors and messages circulating encouraged by the Ministry of AYUSH on social networking platforms which claims it to be prophylactic and should take proper care medicine for unexposed asymptomatic according to guidelines released by population. In conclusion, even respective nation’s governments though finding vaccines and other and the WHO. therapeutic options for COVID-19 as Stay home, stay safe. fast as possible is paramount, proper safety and toxicity studies should be undertaken for the welfare of the society.
4 NOT ON THE SAME BOAT We've heard we’re all in the same boat, rowing our way through the sea of gloom But it’s not like that We’re in the same storm, but not the same boat Your boat might fall prey to the havoc, but mine may not Or vice versa For some, quarantine is a period filled with optimism, a moment of introspection, and reconnection. For some, this is nothing but a crisis. Yet for some, it’s a turmoil- how am I going to pay my bills? Some have all their needs fulfilled as they conveniently “stocked up”, While some are looking through trash to survive. Some believe to be patient and have faith as miracles do happen, While others believe that the worst is yet to come. So, you see, we’re all in a different boat, sailing through these difficult times of global crisis. We all have different needs and perceptions, and everyone will eventually emerge from this. We’re all on different boats, let’s find our way through united and navigate peacefully. - MONALISHA JENA SECOND YEAR BHARATI VIDYAPEETH'S COLLEGE OF PHARMACY
5 IPA-MSB-SF During COVID GENERAL SECRETARY COMMITTEE The General Secretary Committee EDITORIAL COMMITTEE co-ordinates with the committees for organizing events and makes sure that they are executed smoothly. It is responsible for drafting letters and reports, giving direction and clarity for the development of the association. They manage the planning and delivery of the association’s activities in the best interests of the organization and its members. The Editorial Committee designs ID cards and brochures for various events conducted by IPA-MSB-SF. They also publish the annual magazine PANACHE which includes scientific articles by students, exclusive interviews with the stalwarts of the Pharmaceutical Industry, chronicles of the yearly activities and achievements of IPA-MSB-SF. Events organized: Literati
6 STUDENT EXCHANGE FINANCE COMMITTEE OFFICE Overseeing finances plays a vital role in the smooth functioning of This committee gives students the any organization. At IPA-MSB-SF, opportunity to experiment with the Finance committee works with various avenues of the this aim in mind. The Committee Pharmaceutical profession such as looks into the needs of the Hospital & Clinical Pharmacy. running of the Student Forum and helps to maintain a stable Events organized: financial record. Make the Most of May - Online Awareness Quiz (in collaboration with PEO and Finance). National Pharmacy Week- Pharmacy Communal Sessions (in collaboration with Sports Committee)
7 CULTURAL COMMITTEE The Cultural Committee of IPA-MSB-SF brings out the best in every Pharmacy student, through its plethora of year-round cultural events. Events organized: Make the Most of May- Quarantoons Navratri 2020 Lightex: Light It Up Aesthetica PUBLIC RELATIONS OFFICE They effortlessly manage registration work, maintain stellar social media accounts, and promote the year-round activities of the Student Forum among the students. Events organized: Make the Most of May- Quarantine Diaries Treasure Hunt
8 PHARMACY EDUCATION OFFICE The Pharmacy Education Office meticulously organizes workshops, seminars, and training programs that touch on different aspects of Pharmaceutical field. Events organized: Techtober: Scientific Abstract Writing Competition Infographics (in collaboration with Public Health Office) PUBLIC HEALTH OFFICE They strive to highlight the importance of Pharmacists as healthcare professionals by organizing campaigns and health awareness programs. Events organized: Make the Most of May- Article Writing Workshop on Indian Sign Language
9 EXECUTIVE COMMITTEE Overseeing of logistics and other event-related activities are required for the smooth functioning of the events. This committee works towards the felicitation of all winners and the participants of all pharmacy colleges, by arranging and designing all of their rewards like certificates and trophies. SPORTS COMMITTEE The Sports Committee of IPA-MSB-SF organizes a myriad of sports events throughout the year that draws huge participation from pharmacy students. Events organized: Sports Quiz Among Us: Hide N Seek
10
11
12 THE CRISIS THE TURN OF FORTUNES AND CRISIS WAS UNFURLED, LITTLE BY LITTLE THINGS HAVE CHURNED, THE PEST WAS AWAKENED. MINUTE WAS ITS APPEARANCE, THOUGH DISASTROUS IT'S CONSEQUENCES. CLOSED WERE ALL THE ONCE OPENED DOORS, THE MONOTONOUS LIFE WAS ON HOLD, STREETS EMPTY AND SILENCED, EVERY SECTOR FURTHER TENSED. NOT JUST WHERE THE STAKE OF BEING, BUT ALSO THE GOVERNING. HOPES WERE ALL IN DISMAY, EVERYTHING WAS AT THE BAY, YET AS THE GOLDEN WORDS SAY, NO DARKNESS LAST LONG TILL THE DAYS, THE SAVIORS AROSE LIKE THE RAYS. STOOD AS THE BARRIERS THEIR LABORS LET NO COMPROMISE. SOMETIMES THEY WERE IN MASKS, SAVING HUMANITY AS A PRIME TASK, STRIVING FROM DAWN TO DUSK. OR THEY WERE THE HELPING HANDS, JOINING THE ACT OF DEFENDING. MAYBE IT WOULD A LONG WHILE, TO WIN OVER THIS CRUCIAL BATTLE FOR THE DISRUPTED THINGS TO SETTLE, AS ALL THE BAD TIMES PASSES, THIS MAY ALSO TO CULMINATE. ALL THAT COUNTS IS TO STAY FIRM, WITH NEVER LOSING FAITHS. -RUSHALI SARFARE SECOND YEAR SARASWATI VIDYA BHAVAN'S COLLEGE OF PHARMACY
13 INDIA IN TIMES OF COVID HOW ONE OF THE WORLD'S MOST POPULATED COUNTRY TACKLED THE PANDEMIC H/ 15 : PHASE-1 CLINICAL TRIALS OF INDIA’S FIRST INDIGENOUS COVID-19 VACCINE, JULY COVAXIN, DEVELOPED BY HYDERABAD-BASED PHARMACEUTICAL COMPANY BHARAT BIOTECH IN COLLABORATION WITH THE NATIONAL INSTITUTE OF VIROLOGY AND INDIAN COUNCIL OF MEDICAL RESEARCH, STARTS ACROSS THE COUNTRY. ZYDUS CADILA ALSO STARTS HUMAN TRIALS OF ITS ZYCOV-D VACCINE. CLINICAL TRIALS FOR INDIA’S FIRST INDIGENOUS COVID-19 VACCINE, COVAXIN, STARTED ACROSS THE COUNTRY ON JULY 15. WHILE 375 VOLUNTEERS WILL BE ENROLLED IN PHASE 1 OF THE HUMAN CLINICAL TRIAL, PLANS ARE UNDERWAY TO ENROLL A TOTAL OF 1,125 FOR BOTH PHASES.
26 SERUM INSTITUTE OF INDIA STARTS INDIA TRIALS OF COVISHIELD, THE 14 AUG UNIVERSITY OF OXFORD-ASTRAZENECA VACCINE CANDIDATE, WITH TWO VOLUNTEERS IN PUNE’S BHARATI VIDYAPEETH MEDICAL COLLEGE RECEIVING THE FIRST SHOTS. THE PHASE 2 HUMAN TRIALS OF OXFORD UNIVERSITY’S COVID-19 VACCINE, MANUFACTURED AT THE PUNE-BASED SERUM INSTITUTE OF INDIA, BEGAN ON TUESDAY, WITH THE FIRST DOSE OF VACCINE SET TO BE ADMINISTERED TO SIX TRIAL PARTICIPANTS AT THE BHARATI VIDYAPEETH MEDICAL COLLEGE AND HOSPITAL IN PUNE SERUM INSTITUTE OF INDIA HALTS CLINICAL TRIALS OF THE COVID-19 10 VACCINE CANDIDATE DEVELOPED BY UNIVERSITY OF OXFORD AS SEPT ASTRAZENECA PAUSES GLOBAL TRIALS AFTER ONE PARTICIPANT DEVELOPED A “POTENTIALLY UNEXPLAINED ILLNESS”. THIS DECISION WILL NOT IMPACT TESTING TIMELINES IN INDIA - SERUM INSTITUTE OF INDIA (SII) 16 HYDERABAD-HEADQUARTERED DRUGMAKER DR SEPT REDDY’S LABORATORIES (DRL) ENTERS INTO AN AGREEMENT TO HELP CONDUCT PHASE III HUMAN TRIALS OF RUSSIA’S SPUTNIK V COVID-19 VACCINE IN INDIA. FIRM TO DISTRIBUTE UP TO 100 MILLION DOSES FOR “MASS VACCINATION” IN THE COUNTRY. 19 THE DRUG CONTROLLER GENERAL OF INDIA (DGCI) APPROVES COUNTRY’S FIRST SEPT CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC (CRISPR) COVID-19 TEST FOR COMMERCIAL LAUNCH. JOINTLY DEVELOPED BY COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (CSIR) AND TATA GROUP, THE TEST HAS BEEN NAMED ‘FELUDA’.
IN NOVEMBER 2020, COVAXIN RECEIVED THE APPROVAL TO 15 CONDUCT PHASE III HUMAN TRIALS AFTER COMPLETION OF PHASE NOV I AND II. THE TRIAL INVOLVES A RANDOMISED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY AMONG VOLUNTEERS OF AGE GROUP 18 AND ABOVE AND STARTED ON 25 NOVEMBER. THE PHASE III TRIALS WILL INVOLVE AROUND 26,000 VOLUNTEERS FROM ACROSS INDIA. THE PHASE III TRIALS WILL COVER A TOTAL OF 22 SITES CONSISTING SEVERAL STATES IN THE COUNTRY, INCLUDING DELHI, KARNATAKA AND WEST BENGAL, AND MANY OTHER STATES ARE EXPECTED TO JOIN SOON. REFUSAL RATE FOR PHASE III TRIALS WAS MUCH HIGHER THAN THAT FOR PHASE I AND PHASE II. AS A RESULT, ONLY 13,000 VOLUNTEERS HAD BEEN RECRUITED BY 22 DECEMBER WITH THE NUMBER INCREASING TO 23,000 BY 5 JANUARY 2021. 3 JAN THE DRUGS REGULATORY AUTHORITY GAVE 2021 THE GREEN LIGHT TO THE JABS DEVELOPED BY ASTRAZENECA WITH OXFORD UNIVERSITY AND BY LOCAL FIRM BHARAT BIOTECH. PRIME MINISTER NARENDRA MODI CALLED IT \"A DECISIVE TURNING POINT\". INDIA PLANS TO VACCINATE SOME 300 MILLION PEOPLE ON A PRIORITY LIST THIS YEAR. AFTER LAUNCHING THE WORLD'S LARGEST VACCINATION DRIVE, INDIA HAS SHIPPED TENS OF THOUSANDS OF FREE DOSES OF COVID-19 VACCINES TO NEIGHBOURING COUNTRIES IN WHAT IS BEING WIDELY DESCRIBED AS \"VACCINE DIPLOMACY\".
16 VACCINES AROUND THE WORLD ● IN FEBRUARY 2020, THE WHO SAID IT DID NOT EXPECT A VACCINE AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2), THE CAUSATIVE VIRUS, TO BECOME AVAILABLE IN LESS THAN 18 MONTHS. ● BY APRIL 2020, CEPI RESEARCHERS IDENTIFIED 115 VACCINE CANDIDATES AGAINST COVID-19 THAT WERE AT VARYING STAGES OF DEVELOPMENT. ALSO IN APRIL, CEPI BACKED SIX OF THE VACCINE CANDIDATES AGAINST COVID‑19 THAT SHOULD UNDERGO PHASE II–III TRIALS AND SHOULD BE STREAMLINED THROUGH REGULATORY AND QUALITY ASSURANCE FOR EVENTUAL LICENSING AT A TOTAL COST OF AT LEAST US $2.1 BILLION. ● AS OF 14 JANUARY 2021, 35.3 MILLION DOSES OF THE COVID-19 VACCINE HAD BEEN ADMINISTERED WORLDWIDE BASED ON OFFICIAL REPORTS FROM NATIONAL HEALTH AGENCIES.
17 ON 2 DECEMBER 2020, THE UNITED KINGDOM'S MEDICINES ON 11 AUGUST 2020, RUSSIA AND HEALTHCARE PRODUCTS REGULATORY ANNOUNCED THE APPROVAL OF ITS AGENCY (MHRA) GAVE TEMPORARY REGULATORY SPUTNIK V VACCINE FOR APPROVAL FOR THE PFIZER–BIONTECH VACCINE, EMERGENCY USE, THOUGH ONE BECOMING THE FIRST COUNTRY TO APPROVE THIS VACCINE MONTH LATER ONLY SMALL AND THE FIRST COUNTRY IN THE WESTERN WORLD TO AMOUNTS OF THE VACCINE HAD APPROVE THE USE OF ANY COVID-19 VACCINE. BEEN DISTRIBUTED FOR USE OUTSIDE ON 11 DECEMBER 2020, THE UNITED STATES OF THE PHASE 3 TRIAL. FOOD AND DRUG ADMINISTRATION (FDA) GRANTED AN EMERGENCY USE AUTHORIZATION (EUA) FOR THE PFIZER- BIONTECH COVID-19 VACCINE. A WEEK LATER, THEY GRANTED A EUA FOR MRNA- 1273, THE MODERNA VACCINE. ON 25 JUNE 2020, CHINA APPROVED THE CANSINO VACCINE FOR LIMITED USE IN THE MILITARY AND TWO INACTIVATED VIRUS VACCINES FOR EMERGENCY USE IN HIGH-RISK OCCUPATIONS. AS OF 21 DECEMBER 2020, MANY COUNTRIES IN OCTOBER 2020, THE AUSTRALIAN AND THE EUROPEAN UNION HAVE AUTHORIZED THERAPEUTIC GOODS ADMINISTRATION (TGA) OR APPROVED THE PFIZER-BIONTECH COVID-19 GRANTED PROVISIONAL VACCINE. BAHRAIN AND THE UNITED ARAB DETERMINATIONS TO ASTRAZENECA PTY LTD EMIRATES GRANTED EMERGENCY MARKETING IN RELATION TO ITS COVID‑19 VACCINE, AUTHORIZATION FOR BBIBP-CORV, CHADOX1-S [RECOMBINANT], AND TO PFIZER MANUFACTURED BY SINOPHARM. AUSTRALIA PTY LTD IN RELATION TO ITS COVID-19 VACCINE
18
19
20
EDITORIAL COMMITTEE 21 Sneha Shinde Editor-in-Chief Sonali S. Mrunmayi L. Associate Editor Associate Editor Avdhi P. JOominkt EadriGto.r Joint Editor Nandita P. Sakshi U. Michelle D. Karuna S. Sneha G. Sanjana G. Kruti P.
22 SNEHA SHINDE editor in chief \"Its not about how much we lost; its about how much we have left. Keeping these lines by Tony Stark as our ardent motto, the Editorial board and IPA-MSB-SF as a collective family, kept striding forward. 2020 made us realize the uncertainty of things, of how feeble the human spirit stands in front of nature. \"But a thing isn't beautiful because it lasts. It is a privilege to be among them,\" Adapting to the new reality, we emerged stronger than ever, with undaunted spirits, an armor of steel and hearts of gold. We got acquainted with new technologies, ventured into new lifestyles by thinking out of the box to organize various events and make this year, despite all of its shortcomings, worth it. These unprecedented times, carve pathways to survive, to battle our worst demons and choose to run towards our problems; not away from them. Because we all, in our own way, are our own heroes.
GENERAL SECRETARY 23 COMMITTEE Ratnakar Manchakatla Chairperson Maryam Pathan Vice-Chairperson and Pharmacy Education Officer Preetika Pathare Pravin Tak Joint General Secretary Joint General Secretary
24 RATNAKAR MANCHAKATLA Chairperson The year 2020 was an unprecedented year for all of us, and we at IPA-MSB-SF experienced the same. The online world seemed to put a lot of restrictions on our interaction and enthusiasm, but we never let it dampen our spirit! I am grateful that all of us stuck together like a family and did what every family does - overcome the hurdles thrown at us together. I have always aimed for IPA-MSB-SF to strive for the betterment of our profession and our society, and we intend to do that in this pandemic too. I feel happy to announce that we are ready to plan a virtual Rx and keep the indomitable spirit of IPA-MSB-SF alive and kicking!
CULTURAL COMMITTEE 25 Alisha D'Souza Cultural Secretary Gauri M. Heenakshi C. Prerana S. Associate Cultural Secretary Associate Cultural Secretary Associate Cultural Secretary Joint CuRlthueraal SSe.cretary Joint COumltukraalrSDec.retary Mansi B. Prachi C. Swarali L. Shreelekha D. Nihant S. Sakshi P. Nidhi V. Sarvesh D. Janhvi B. Jaanvi C.
26 ALISHA D'SOUZA cultural secretary Covid-19 has exposed us to inadequacies in different sectors similarly it has been a great impediment for IPA-MSB-SF too. Nothing beats the essence of togetherness, networking and exposure which could be easily experienced by looking around during the physical events. Our prime focus is to offer the same opportunities for building social contact and interactions while digitalising our events. As this is a new territory for us all we are ready to take on these new responsibilities and break the new ground. This scenario demands us to be well prepared for any consequences faced by our participants as things are new to us it's new to them as well. We are steered to be more creative in combining technology with our skills. By small efforts put in by each team member I believe that we will vanquish this hurdle and achieve the best together.
SPORTS COMMITTEE 27 SpMoerthsuSlecJraeitnary Rohan C. AssocAiantekSitpJo.rts Secretary Associate Sports Secretary Hrituja K. Joint SApnoritsshSSe.cretary Aditya D. Joint Sports Secretary Joint Sports Secretary Sakshi G. Shahnawaz S. Mansi K. Jonathan A. Atharva W. Nakshee M. Udit S. Ishan S. Tejas P. Rohit G.
28 MEHUL JAIN sports secretary This year has been a rocky road with every day being a new challenge for everyone. We at IPA-MSB-SF certainly knew one thing that coming up with new ideas is going to be this year's main driving force. This year we weren’t going to be tested only for our management skills but also our imagination and ingenuity. It was my privilege to be chosen as the Sports Secretary for the year 2020-2021. Although we were well aware of the fact that this year to conduct events on the field could be unachievable and planning and executing an online event was going to be a strenuous task, with the assist of technology and the capabilities of all my team members we were able to execute online events and were well prepared for any hurdles that we would face. As of now the journey of this year has been gratifying with every day being a new challenge to tackle and a new experience to learn from and we hope to proceed forward with the same enthusiasm and face every obstacle without letting our inner blaze moribund.
PUBLIC RELATIONS OFFICE 29 Dimple Rohera Public Relations Officer Manjari S. Ganesh S. Purva K. Associate Public Relations Officer Associate Public Relations Officer Associate Public Relations Officer Marilyn K. Jayesh N. Samruddhi K. Vaishnavi P. Joint Public Relations Officer Joint Public Relations Officer Joint Public Relations Officer Joint Public Relations Officer Rachel T. Shubham C. Chahat B. Sameer C. Navya D. Nitya P.
30 DIMPLE ROHERA public relations officer \"You can do what I cannot do. I can do what you cannot do. Together, we can do great things. I, Dimple Rohera, the Head of Public Relations Office for the year 2020-21, etched these words of Mother Teresa in my heart, which helped me be true to myself, throughout my journey in IPA-MSB-SF. 2020 had been a year full of challenges, new goals and adventures, but with great teamwork, hard work and dedication, come great results. Our social media platforms are a proof of the same. We were able to bridge the gap between students, healthcare workers and everyone else through our daily events on Instagram, campaigns and by spreading awareness about the UNO and WHO Health days.
PUBLIC HEALTH OFFICE 31 Manasi Danedekar Public Health Officer Amruta K. Sagar P. Associate Public Health Officer Associate Public Health Officer Jahanvee K. Shreya S. Sakshi S. Monalisha J. Joint Public Health Officer Joint Public Health Officer Joint Public Health Officer Joint Public Health Officer Rasika C. Pinki J. Hardika P. Akshata S. Smit B. Janhavi P. Vaishnavi A. Anupama N. Prachi K.
32 MANASI DANDEKAR public health officer The year 2020 has been challenging for everyone with people facing new difficulties with each passing day, as we got to see the glimpses of the possible emergencies we would have to face in the future. Being in the Public Health Office of IPA-MSB-SF, we tried our best to spread awareness among the students and the general public regarding various health related disorders. The Public Health Protocol was also modified to suit the current situation and tough times. The pandemic has truly taught us to face all the challenges coming our way and keep a positive attitude to move ahead in life. It has also helped us to elevate our sense of responsibilities as a pharmacist and know the true valor of our profession in depth.
PHARMACY EDUCATION 33 OFFICE Maryam Pathan Vice-Chairperson & Pharmacy Education Officer Akash G. Anish P. Vrushti T. Associate Pharmacy Education Officer Associate Pharmacy Education Officer Associate Pharmacy Education Officer Noma V. Aakansha B. Raghadeep S. Kunal W. Joint Pharmacy Education Officer Joint Pharmacy Education Officer Joint Pharmacy Education Officer Joint Pharmacy Education Officer Anushka S. Himanshu J. Gunika G. Priti Y.
34 MARYAM PATHAN vice- chairperson and pharmacy education officer \"The outbreak of COVID-19 pandemic led the fast moving world to a standstill, and a small virus has changed the dynamics of the entire world in a snap! But no matter how much falls on us, we keep plowing ahead, and I feel very proud to say that this is exactly what we, at IPA-MSB-SF, did. Despite all the restrictions posed by the pandemic, we made sure that we do our best to uplift everyone’s spirit. We organised various online programs for the students and helped them realise their inner talents. And, now we are on our way to conduct our first ever, one of a kind, online Rx! Last but not the least, I would like to say that \"No matter how many hurdles come our way, it is our vision and determination that will help us overcome all of them!\".
STUDENT EXCHANGE 35 OFFICE Gaurav Zope Student Exchange Officer Yukta D. Jugal P. Soham D. Associate Student Exchange Officer Associate Student Exchange Officer Associate Student Exchange Officer Kirtish P. Shruti K. Shraddha M. Atharva B. Joint Student Exchange Officer Joint Student Exchange Officer Joint Student Exchange Officer Joint Student Exchange Officer Utkarsha M. Purv G. Ankita P. Sahana M.
36 GAURAV ZOPE student exchange officer With memories of last Rx and even more excitement, I stepped into the year 2020. Little did I know, this year was going to be so different than imagined. It brought along newer sets of challenges. Most of the activities carried out by SEO are based on informative, yet enjoyable field visits. Switching to conducting online events, that would provide same level of experience to the participants, was a tough job indeed. But with the help of the team and their creativity, we could develop various events. With the same level of zeal, we are anticipating organizing programs and events for bringing out the suitable aptitude from amongst the students. Even now, we are looking forward to the days when we might restart our old events with full spirit.
EXECUTIVE COMMITTEE 37 Omkar Kulkarni Cheif Executive Officer Punam C. Aditi D. Shannon C. Associate Executive Officer Associate Executive Officer Associate Executive Officer Aditi S. Sreehari N. Rishabh I. Joint Executive Officer Joint Executive Officer Joint Executive Officer Treesa A. Aditi D. Ankita N. Neel P. Anjali M. Aishwarya C. Vidya D. Rukaiyah B. Yukta M. Janvi S.
38 OMKAR KULKARNI chief executive officer 2020 started with an amazing Rx. But nobody could’ve expected what was to come. The year presented itself as a huge task to us, but being the family that we are, we tried our best to work with it. With everything online, it was tiring to interact with the screen, but we still kept our eyes on the goal, and walked the path together. A lot of events came and went. And a lot more are yet to come. We aim to keep interacting with all of you, and keep the enthusiasm alive. Taking all the positives we can from this year, we aim to make this Rx and this year a good one!
FINANCE COMMITTEE 39 Rahul Jaiswal Finance Director Aaliya K. Associate Finance Director Joint ZFiunahnaceirDBir.ector JoinSt FriunasnhcteiDMir.ector Joint FTinaanncveiDPir.ector Afreen M. Nivedita S. Bhargavi N. Smit U. Devika S.
40 RAHUL JAISWAL finance director \"Covid-19, nobody would ever forget this pandemic their whole lifetime. It made me realize how important it is to keep ourselves healthy, as well as to maintain mother nature with love and care. As the Head of Finance Committee in IPA- MSB-SF, I also realized that we need to make changes, and take our fest Rx online this year but to get sponsors had been an arduous task. I got acquainted with some new habits that enlightened my mind, and made me think about life with a different perspective. We aren't sure about tomorrow, but our actions of today will definitely help us make it better. So let's do our bit together, and make this world a better place for all the living beings.
41 IMPACT OF COVID 19 ON THE ENVIRONMENT JASMINE PRUTHI INSTITUTE OF CHEMICAL TECHNOLOGY THE NEW SARS-COV2 HAS GENERATED AN UNRIVALLED IMPACT IN MOST COUNTRIES. THE VIRUS HASAFFECTED ALMOST EVERY COUNTRY AND SPREAD TO MORE THAN 2 MILLION PEOPLE, CAUSED AROUND 130,000 DEATHS. MANY COUNTRIES HAVE PRACTISED SOCIAL DISTANCING AND SCREENING PROCESS TO CONTROL THE SPREAD OF THE VIRUS. THE LITERATURE ON THE INDIRECT ENVIRONMENTAL IMPACT OF THE VIRUS IS SCANT WHERE POSITIVE INDIRECT ENVIRONMENTAL IMPACT CAN BE ACCOUNTED AS THE DROP VIZ. GREENHOUSE GAS EMISSIONS, AIR POLLUTION AND EXTENSIVE BEACH CLEAN-UPS. IT IS ALSO IMPORTANT TO NOTE THE NEGATIVE EFFECTS I.E. SUSPENSION OF RECYCLING PROGRAMMES, HAMPERED SUSTAINABLE WASTE MANAGEMENT SYSTEMS AND INCREASING DOMESTIC WASTE. THIS ARTICLE AIMS TO ENCOMPASS THE POSITIVE AND NEGATIVE INDIRECT ENVIRONMENTAL EFFECTS OF THE SARS-COV2 CORONAVIRUS.. 1. Decreased Concentrations of NO2 Henceforth, the Copernicus Sentinel- & PM 2.5: Air quality is essential 5P satellite readings showed for people's health. However, 91% of remarkable NO2 reductions in many the world population lives in places European cities. These air quality where air quality exceeds the improvements have generated human permissible limits leading to 8% health benefits that have global mortality each year. Due to outnumbered confirmed SARS-CoV2 quarantine, NO2 has reduced by death in China. 22.8 and 12.9 μg/m3 in Wuhan and China, respectively. PM-2.5 2. Clean Beaches: decreased by 1.4 μg/m3 in Wuhan Beaches are one of the most important and 18.9 μg/m3 in 367 cities. natural capital assets providing critical survival services to the coastal communities.
42 IMPACT OF COVID 19 ON THE ENVIRONMENT JASMINE PRUTHI INSTITUTE OF CHEMICAL TECHNOLOGY However, non-responsible use and Due to pandemic, countries such as the over-exploitation have caused many USA has stopped critical recycling pollution problems. The lack of tourists programs in some of their cities to due to pandemic has resulted in mitigate the risk of spreading COVID- remarkable changes in the 19. appearances of beaches throughout the world CONCLUSION: 3. Increased Waste: This article comprehends the positive The organic and inorganic waste and negative environmental indirect generation is indirectly resulting in effects of COVID-19. The positive environmental issues. The quarantine indirect effects revolve around the policies have increased demand for reduction of PM-2.5 and NO2 online shopping. Consequently, concentrations. Where the increase in household’s organic and inorganic domestic and medical waste accounts waste has increased. for the negative effects. To conclude, COVID-19 will produce both positive 4. Reduction in Waste Recycling and negative environmental impacts Waste recycling has always been a which require long-term structural major environmental problem economic change. Furthermore, some worldwide. Recycling is a common and environmental problems may last effective way to prevent pollution and longer and challenging to manage if conserve natural resources. neglected. .
43 IMPACT OF COVID 19 ON THE ENVIRONMENT JASMINE PRUTHI INSTITUTE OF CHEMICAL TECHNOLOGY POSITIVE EFFECTS: •After 30 years, South Asian River Dolphins also known as Ganges Dolphins have been spotted back in the Ganga river. • Tens of thousands of flamingos have gathered in the city of Navi Mumbai. • The Uttarakhand Pollution Control Board Water from Har-ki-Pauri in Haridwar was tested and the results from the tests reveal that the water here has been classified as 'fit for drinking after chlorination', for the first time in decades. REFRENCE: https://sputnikvaccine.com/about-vaccine/clinical-trials/ https://www.fda.gov/media/144412/download#:~:text=On%20Decem ber%2011%2C%202020%2C%20the,of%20Authorization%20(Section %20II)%20of https://www.gov.uk/government/publications/regulatory-approval- of-pfizer-biontech-vaccine-for-covid-19 https://apps.who.int/gpmb/assets/pdf/GPMB_6March2020statement .pdf https://www.reuters.com/article/us-health-coronavirus-china- vaccine-idUSKBN2400DZ https://www.pfizer.com/news/press- release/press-release-detail/pfizer-and-biontech-receive- authorization-european-union https://www.tga.gov.au/tga-grants- provisional-determination-covid-19-vaccine https://www.who.int/news-room/news-updates
44 RAISING THE BEST IN OURSELF. Sparkles of light Give corona a fight. Spread positive vibes Respect the people Who risk their lives. During the tough times, To protect our life Nothing can separate our unity During the crisis time. Light a lamp to enlighten our soul and minds, Having faith in our will and courage to fight. Just say that the rise of hope will cross its heights Clear all misunderstandings and make a new beginning for all the aspects of life. See every aspect of life with a new vision Let's clear the fog of fear and webs in mind to achieve our mission. -SAANIKA SATHE SECOND YEAR NCRD'S STERLING INSTITUTE OF PHARMACY
Name: Sakshi Upadhyay 45 Year: Second Year G College: Mumbai Educational Trust Institute Of Pharmacy ART L VOILA L E AMOUR R Y Name: Anwesha Singh Year: Second Year College: DY Patil University School Of Pharmacy
46 Youth leading the way with
47
Search
